Why is OptimizeRx Corp. ?
1
The company has declared positive results for the last 4 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at USD 14.63 MM
- ROCE(HY) Highest at 5.56%
- DEBT-EQUITY RATIO (HY) Lowest at 2.74 %
2
With ROE of 4.19%, it has a very attractive valuation with a 0.97 Price to Book Value
- Over the past year, while the stock has generated a return of -65.02%, its profits have risen by 142.6% ; the PEG ratio of the company is 0.2
3
High Institutional Holdings at 100%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
How much should you buy?
- Overall Portfolio exposure to OptimizeRx Corp. should be less than 10%
- Overall Portfolio exposure to Software Products should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Software Products)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is OptimizeRx Corp. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
OptimizeRx Corp.
-63.26%
-0.76
79.39%
S&P 500
20.78%
1.67
13.28%
Quality key factors
Factor
Value
Sales Growth (5y)
20.37%
EBIT Growth (5y)
50.16%
EBIT to Interest (avg)
-4.63
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.14
Sales to Capital Employed (avg)
0.60
Tax Ratio
4.37%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
23
Industry P/E
Price to Book Value
0.97
EV to EBIT
10.47
EV to EBITDA
7.71
EV to Capital Employed
0.97
EV to Sales
1.15
PEG Ratio
0.16
Dividend Yield
NA
ROCE (Latest)
9.22%
ROE (Latest)
4.19%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
Technical Movement
21What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 14.63 MM
ROCE(HY)
Highest at 5.56%
DEBT-EQUITY RATIO
(HY)
Lowest at 2.74 %
RAW MATERIAL COST(Y)
Fallen by -25.57% (YoY
PRE-TAX PROFIT(Q)
At USD -0.64 MM has Grown at 80.32%
NET PROFIT(Q)
At USD -0.49 MM has Grown at 77.49%
-3What is not working for the Company
NET SALES(Q)
Lowest at USD 19.84 MM
Here's what is working for OptimizeRx Corp.
Operating Cash Flow
Highest at USD 14.63 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Debt-Equity Ratio
Lowest at 2.74 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Pre-Tax Profit
At USD -0.64 MM has Grown at 80.32%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Net Profit
At USD -0.49 MM has Grown at 77.49%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
Raw Material Cost
Fallen by -25.57% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for OptimizeRx Corp.
Net Sales
Lowest at USD 19.84 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (USD MM)






